Ascend Wellness Holdings (AAWH) Non-Current Deferred Tax Liability (2021 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Non-Current Deferred Tax Liability of $20.2 million in Q1 2026, down 6.15% quarter-over-quarter from $21.5 million in Q4 2025, and down 14.17% on a YoY basis from $23.5 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends
Ascend Wellness Holdings' Non-Current Deferred Tax Liability history runs 6 years deep, the most recent figure standing at $20.2 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 14.17% year-over-year to $20.2 million; the TTM figure through Mar 2026 stood at $20.2 million (down 14.17% YoY), while the FY2025 annual figure was $21.5 million, down 8.21% from the prior year.
- Non-Current Deferred Tax Liability was $20.2 million for Q1 2026 at Ascend Wellness Holdings, down from $21.5 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $37.1 million in Q3 2023 to a low of $276000.0 in Q1 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $25.8 million across 5 years, with a median of $25.6 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability soared 11292.03% in 2023, then slumped 34.43% in 2024.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $33.6 million in 2022, then rose by 6.36% to $35.7 million in 2023, then plunged by 34.43% to $23.4 million in 2024, then slipped by 8.21% to $21.5 million in 2025, then slipped by 6.15% to $20.2 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $20.2 million (Q1 2026), $21.5 million (Q4 2025), and $18.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.19 Mn |
| Mar 31, 2026 | 20.19 Mn |
| Dec 31, 2025 | 21.52 Mn |
| Dec 31, 2025 | 21.52 Mn |
| Sep 30, 2025 | 18.74 Mn |
| Sep 30, 2025 | 18.74 Mn |
| Jun 30, 2025 | 20.92 Mn |
| Jun 30, 2025 | 20.92 Mn |
| Mar 31, 2025 | 23.53 Mn |
| Mar 31, 2025 | 23.53 Mn |
| Dec 31, 2024 | 23.44 Mn |
| Dec 31, 2024 | 23.44 Mn |
| Sep 30, 2024 | 25.57 Mn |
| Sep 30, 2024 | 25.57 Mn |
| Jun 30, 2024 | 30.27 Mn |
| Jun 30, 2024 | 30.27 Mn |
| Mar 31, 2024 | 32.48 Mn |
| Mar 31, 2024 | 32.48 Mn |
| Dec 31, 2023 | 35.75 Mn |
| Dec 31, 2023 | 35.75 Mn |